ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs68.01 M130.41 M94.54 M91.65 M97.27 M133.46 M416.92 MRecherche et développement———————Résultat d'exploitation102.88 M52.58 M76.48 M90.95 M122.91 M275.34 M565.68 MTotal des produits hors exploitation———————Charges d'intérêts, nettes des intérêts capitalisés———————Résultat hors exploitation, hors charges d'intérêts———————Revenus/dépenses exceptionnels———————Résultat avant impôts102.88 M52.58 M76.48 M90.95 M122.91 M80.39 M370.73 MPart des actionnaires dans le résultat———————Impôts11.88 M-21.59 M15.04 M16 M23.73 M-8.87 M45.9 MIntérêts ne donnant pas le contrôle / intérêts minoritaires39.69 M20.15 M28.54 M35.12 M45.82 M28.75 M138.23 MAutres produits/charges après impôts-2.23 M210 K5.02 M1.24 M-2.54 M2.69 M6.41 MRésultat net avant activités abandonnées51.3 M54.02 M32.9 M39.84 M53.36 M60.5 M186.6 MActivités abandonnées———————Résultat net51.3 M54.02 M32.9 M39.84 M53.36 M60.5 M186.6 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires82.24 M88.63 M52.38 M65.25 M-15.09 M95.64 M198.18 MBénéfice par action de base (BPA de base)2.022.121.261.552.072.317.19Bénéfice par action dilué (BPA dilué)1.841.991.221.491.982.216.9Nombre moyen d'actions de base en circulation25.45 M25.52 M25.68 M25.7 M25.72 M26.23 M—Nombre d'actions en circulation après dilution44.11 M44.46 M43.95 M43.9 M28.61 M43.28 M—EBITDA106.08 M55.79 M79.76 M94.36 M126.35 M84.33 M384.8 MEBIT102.88 M52.58 M76.48 M90.95 M122.91 M80.39 M370.73 MCoût des ventes———————Autres coûts des ventes———————Amortissements (flux de trésorerie)3.21 M3.21 M3.28 M3.41 M3.44 M3.95 M14.08 M
PJT Partners Inc. Class A Common Stock
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
PJT operates businesses across strategic advisory, strategic capital markets, restructuring, shareholder advisory and capital raising. The firm has advised on over $1 trillion in M&A transactions including AbbVie's $63 billion acquisition of Allergan, T-Mobile's $59 billion merger with Sprint, and Mylan's $50 billion merger with Pfizer subsidiary, Upjohn.
The firm is headquartered in New York City, with additional offices in Boston, Chicago, Hong Kong, Houston, London, Los Angeles, Madrid, San Francisco and Sydney, and employs approximately 700 people.